Literature DB >> 28148759

Subcutaneous Tocilizumab May Be Less Effective than Intravenous Tocilizumab in the Treatment of Juvenile Idiopathic Arthritis-associated Uveitis.

Estefania Quesada-Masachs1, Consuelo Modesto Caballero2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28148759     DOI: 10.3899/jrheum.160908

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  5 in total

Review 1.  [Association of the different forms of uveitis with inflammatory rheumatic diseases and their treatment].

Authors:  Nicole Stübiger; Sanaz Farrokhi; Yannik Gkanatsas; Christoph Deuter; Ina Kötter
Journal:  Z Rheumatol       Date:  2022-08-30       Impact factor: 1.530

Review 2.  Epidemiological and advanced therapeutic approaches to treatment of uveitis in pediatric rheumatic diseases: a systematic review and meta-analysis.

Authors:  Mohsen Jari; Reza Shiari; Omid Salehpour; Khosro Rahmani
Journal:  Orphanet J Rare Dis       Date:  2020-02-04       Impact factor: 4.123

3.  Tocilizumab and Abatacept for the Treatment of Childhood Chronic Uveitis: A Monocentric Comparison Experience.

Authors:  Ilaria Maccora; Sarah Abu Rumeileh; Franco Curci; Cinzia de Libero; Edoardo Marrani; Maria Vincenza Mastrolia; Ilaria Pagnini; Gabriele Simonini
Journal:  Front Pediatr       Date:  2022-04-12       Impact factor: 3.418

Review 4.  Treating juvenile idiopathic arthritis (JIA)-related uveitis beyond TNF-α inhibition: a narrative review.

Authors:  Carla Gaggiano; Donato Rigante; Gian Marco Tosi; Antonio Vitale; Bruno Frediani; Salvatore Grosso; Claudia Fabiani; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2019-12-10       Impact factor: 2.980

5.  Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial.

Authors:  Athimalaipet V Ramanan; Andrew D Dick; Catherine Guly; Andrew McKay; Ashley P Jones; Ben Hardwick; Richard W J Lee; Matthew Smyth; Thomas Jaki; Michael W Beresford
Journal:  Lancet Rheumatol       Date:  2020-02-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.